Mina S Sedrak
Works at
University of California Los Angeles
Associate professor, director
Sources: reporter.nih.gov
Grants and prizes
R01, Targeting Senescence to Mitigate Chemotherapy-induced Functional Decline, R01CA280088, 2023–2028, 13 Aug 2026
R01, SEN-ENERGY: A Multisite Randomized Controlled Trial to Improve Functional Recovery and Mitigate Frailty after Hematopoietic Cell Transplantation in Older Adults, R01CA314354, 2026–2031, 22 Jul 2026
National Institute of Arthritis and Musculoskeletal and Skin Diseases
R01, Enhancing Skeletal Muscle Recovery and Mitochondrial Function in Older Cancer Survivors, R01AR087145, 2026–2029, 12 Mar 2026
K76, Targeting Senescence to Improve Frailty in Older Cancer Survivors, K76AG074918, 2023–2026, 21 Aug 2024
R21, Using Senolytics to Improve Physical Function in Older Breast Cancer Survivors, R21CA277660, 2022–2025, 1 Dec 2023
Sources: reporter.nih.gov